Cited 0 time in
The Mid-term Outcomes of Posterior or Posterolateral Fusion Using Escherichia Coli-Derived Recombinant Human Bone Morphogenetic Protein2(E. BMP-2) : Minimum 3-Years Follow-up
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
